TRPV3 antagonist 74a

Research use only, not for human use.

TRPV3 antagonist 74a (TRPV3 74a) is a specific TRPV3 antagonist for the study of neurological disorders.

TRPV3 antagonist 74a is a potent and selective TRPV3 antagonist. TRPV3 antagonist 74a displays no significant activity against a panel of other ion channels. TRPV3 antagonist 74a can be used for the research of neuropathic pain.

TRPV3 antagonist 74a (100 μΜ; 2300 seconds; keratinocytes) largely attenuates SLIGRL or SLIGKV-induced Ca2+ responses.

TRPV3 antagonist 74a (150 μg; intradermal injection; 30 minutes) decreases the number of scratches significantly..TRPV3 antagonist 74a (10~100 mg/kg; p.o.) dose-dependently attenuates mechanical allodynia induced by von Frey hair stimulation to the ipsilateral (injured) hind paw. TRPV3 antagonist 74a exhibits anti-nociceptive activity in the reserpine model of central pain by increasing muscle pressure threshold.Animal Model:WT mice Dosage:150 μg Administration:Intradermal injection; 30 minutes Result:The number of scratches decreased significantly.

——

Membrane Transporter/Ion Channel

TRP/TRPV Channel

TRP/TRPV Channel

——

——

1432051-63-2

338.32

C17H17F3N2O2

>98% (HPLC)

——

[C@H](O)([C@]1(C[C@@](C)(O)C1)C2=CC(C(F)(F)F)=CC=N2)C3=CC=CC=N3

——

(-20℃)

With Ice Pack

≥ 2 years